ADPT
Ticker
Adaptive Biotechnologies Corp
Company
Diagnostics
Industry
Healthcare
Sector
Financial Ratio Analysis
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
+
2026
TTM
Revenue Growth YoY
β€”44.8%52.8%15.6%56.9%20.1%-8.1%5.1%54.8%β€”50.1%
Revenue Growth QoQ
β€”44.8%52.8%15.6%56.9%20.1%-8.1%5.1%54.8%β€”β€”
Gross Margin
59.2%64.7%73.8%77.1%68.1%68.7%55.6%59.7%74.2%β€”75.6%
EBITDA Margin
-115.7%-89.4%-92.1%-155.3%-135.4%-108.0%-133.3%-90.8%-20.6%β€”-12.2%
Operating Margin
-115.7%-89.4%-92.1%-155.3%-135.4%-108.0%-133.3%-90.8%-20.6%β€”-12.2%
Profit Margin
-111.4%-83.4%-80.6%-148.6%-134.3%-108.0%-132.3%-89.1%-21.5%β€”-20.7%
FCF / EBITDA
0%0%0%0%0%0%0%0%0%β€”0%